Jian Jhang Huang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The KRAS mutation test is recommended that it may determine which patients with advanced colorectal or lung cancer are eligible for anti-EGFR targeted therapies. Traditional molecular techniques such as polymerase chain reaction (PCR) combined direct sequencing are limited by the difficulty of obtaining patients' cancer tissues for analysis. Finding an(More)
  • 1